Can I read 2020 - Immunotherapy Targeting The PD-1 Pathway For Advanced Urothelial Carcinoma on EtoBox?

2020 - Immunotherapy Targeting The PD-1 Pathway For Advanced Urothelial Carcinoma by dr.tonichen is a document available to read on EtoBox.

What is 2020 - Immunotherapy Targeting The PD-1 Pathway For Advanced Urothelial Carcinoma about?

This meta-analysis evaluated the efficacy and safety of immunotherapy targeting the PD-1 pathway for advanced urothelial carcinoma. It analyzed 14 clinical trials with over 2600 patients and found an objective response rate of 20%, 1-year overall survival rate of 50%, and 1-year progression-free survival rate of 17%. The analysis also reported rates of treatment-related adverse events.

Author

dr.tonichen

Language

EN